MRM — MEDIROM Healthcare Technologies Balance Sheet
0.000.00%
- $16.04m
- $27.58m
- ¥8bn
- 33
- 77
- 38
- 47
Annual balance sheet for MEDIROM Healthcare Technologies, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,440 | 371 | 605 | 106 | 329 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 560 | 855 | 1,325 | 1,228 | 2,002 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,087 | 1,382 | 2,363 | 1,759 | 2,706 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,815 | 2,249 | 2,380 | 2,541 | 2,509 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,713 | 5,753 | 6,747 | 6,849 | 8,091 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,653 | 3,196 | 3,642 | 3,561 | 4,181 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5,222 | 5,961 | 6,807 | 6,638 | 7,157 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 491 | -208 | -59.4 | 211 | 933 |
| Total Liabilities & Shareholders' Equity | 5,713 | 5,753 | 6,747 | 6,849 | 8,091 |
| Total Common Shares Outstanding |